is semaglutide patented Semaglutide's patent expires today. What does it mean for patients, pharma players and Novo Nordisk? Novo Nordisk to lose blockbuster

This compound should only be handled by qualified professionals in appropriate research or laboratory settings

Market growth is fueled by the increased rates of type 2 diabetes and obesity over the world, increased awareness of cardiovascular effects linked to GLP-1 therapies, increased uptake of new dual and triple agonist preparations, and positive regulatory endorsements of weight loss phenotypes

doi:10.1038/s41598-019-49364-x 182

Oral or capsules : Between 100 to 50 mcg, one to two times daily

This 5-8 times longer half-life means the glutathione stays in your blood long enough to be carried throughout your body, enter your cells quickly, and take powerful effect